As a child, Max Hodak learned to develop film in a darkroom with his grandfather who was almost blind. Hodak’s grandfather had retinitis pigmentosa, a congenital disease that affects one out of every ...

Please can you give an introduction to optogenetics? How was this technology inspired by psychiatry? Optogenetics is a way of introducing information into the brain using light, it targets specific ...

With optogenetics, the ability to restore and enhance brain function is becoming a reality. In this World Economic Forum discussion, Nature magazine neuroscience editor I-han Chou explains how the ...

Optogenetics is a technique used for the study of neural circuits in the brain. It is a branch of biotechnology that combines genetics and optical techniques to conceive and control a specific neural ...

The optogenetic revolution is transforming neuroscience. The dramatic recent progress in using light to both control and read out neural activity has highlighted the need for better probes, improved ...

Being able to flip a switch and control a brain sounds like the latest sci-fi movie, but it's a real thing in the field of neuroscience. It's called "optogenetics," and specific frequencies of light ...

Innovative technologies such as artificial intelligence (AI) machine learning and optogenetics are accelerating discoveries in life sciences, especially in the field of neuroscience. A new ...

Optogenetics employs a harmless virus to deliver light-sensitive genes to a particular set of neurons in the brain that can then be switched on and off with pulses of light. In a first, UC researchers ...

Two different research groups, one based at Columbia University and UC Berkeley, and the other at the Vision Institute of Sorbonne University in Paris, introduced a promising approach to study ...

Some big scientific discoveries aren’t actually discovered. They are borrowed. That’s what happened when scientists enlisted proteins from an unlikely lender: green algae. Cells of the algal species ...

Novartis already bought into optogenetic gene therapy technology last year, but the Swiss Pharma wants more. Enter Arctos Medical, which will now join Novartis with its gene therapy program for vision ...